Long-Term Effect Of One Phase III Trial: Benefit For Thousands Of Patients
High Dose Radiotherapy Plus Chemo Encouraging For Small Cell Lung Cancer
Age Shouldn’t Determine Lung Cancer Treatment, ASCO Says In New Guideline
Patch-Lozenge Combination Best For Smoking Cessation
Lower Dose Dexamethasone Can Be Used To Treat Newly Diagnosed Myeloma
Low Total Cholesterol Linked To Higher Risk Of Cancer; Higher HDL Associated With Decreased Risk Of Cancer
Black-White Disparity Seen In End Of Life Treatment
HER2+ Tumors Increase Risk Of Recurrence, Study Finds
The Clinical Cancer Letter To End Print Edition In 2010
NCI Cooperative Group Clinical Trials Approved
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Long-awaited results from first phase III trial of a RAS inhibitor in pancreatic cancer shows that daraxonrasib doubles median OS
PanCAN’s Berkenblit: “It’s here. This is a tipping point, and we’ve tipped. And this is just the beginning.” - Protecting the cure: Why the future of radiation oncology must be precision-guided
- Letai: Perceptions aside, money is flowing and the cancer research infrastructure is sturdy
NCI expects record-breaking spending on extramural research - NCI Director Letai wants you to know: Grant money is flowing again post-government shutdown
- Wafik El-Deiry steps down as director of Brown’s Legorreta Cancer Center
